A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

PHILADELPHIA (WPVI) -- The City of Philadelphia is launching a new program in the Kensington neighborhood on Wednesday, with the goal of sending those with drug addictions to treatment rather than ...

Aspiring candidates can check the registration and exam dates through the official website at tancet.annauniv.edu. The application process will commence on January 24 and conclude on February 21. The ...

5-Fluorouracil (5-FU) is one of the most commonly used chemotherapeutic ... These findings suggested that the 5-FU-loaded PTMC membranes hold great potential for application in cancer patients, ...